Financial Lp Hrt Sells 735,462 Shares of Aditxt (NASDAQ:ADTX) Stock

Aditxt, Inc. (NASDAQ:ADTX) major shareholder Financial Lp Hrt sold 735,462 shares of the company’s stock in a transaction on Friday, June 5th. The shares were sold at an average price of $0.06, for a total transaction of $44,127.72. Following the completion of the sale, the insider directly owned 505,302 shares in the company, valued at $30,318.12. This trade represents a 59.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Thursday, June 4th, Financial Lp Hrt acquired 843,622 shares of Aditxt stock. The stock was acquired at an average cost of $0.08 per share, for a total transaction of $67,489.76.
• On Friday, April 24th, Financial Lp Hrt sold 1,089 shares of Aditxt stock. The shares were sold at an average price of $7.56, for a total transaction of $8,232.84.
• On Thursday, April 23rd, Financial Lp Hrt sold 141 shares of Aditxt stock. The shares were sold at an average price of $7.83, for a total transaction of $1,104.03.
• On Tuesday, April 21st, Financial Lp Hrt acquired 2,700 shares of Aditxt stock. The stock was acquired at an average cost of $8.91 per share, for a total transaction of $24,057.00.
• On Wednesday, April 22nd, Financial Lp Hrt sold 443 shares of Aditxt stock. The shares were sold at an average price of $8.10, for a total transaction of $3,588.30.

Aditxt Price Performance

ADTX stock opened at $0.03 on Wednesday. The firm’s fifty day simple moving average is $6.89 and its 200-day simple moving average is $158.83. The company has a market capitalization of $23,698.00, a P/E ratio of 0.00 and a beta of 0.84. Aditxt, Inc. has a 12 month low of $0.03 and a 12 month high of $53,451.08.

Aditxt (NASDAQ:ADTX) last released its quarterly earnings data on Tuesday, March 31st. The company reported $315,563.31 EPS for the quarter. Aditxt had a negative net margin of 360,152.50% and a negative return on equity of 374.60%.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on ADTX. Wall Street Zen raised shares of Aditxt to a “sell” rating in a report on Saturday, May 23rd. Weiss Ratings reissued a “sell (e+)” rating on shares of Aditxt in a report on Monday, April 20th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

Aditxt Company Profile

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.